His primary scientific interests are in Nuclear medicine, Positron emission tomography, Radiology, Carcinoma and Radiation therapy. Farrokh Dehdashti does research in Nuclear medicine, focusing on Fluorodeoxyglucose specifically. The Fluorodeoxyglucose study combines topics in areas such as Survival rate, Internal medicine, Cervical cancer and Oncology.
Farrokh Dehdashti has included themes like Cancer, Cervix, Tumor hypoxia, Esophagectomy and Tomography in his Positron emission tomography study. His Radiology research is multidisciplinary, relying on both Recurrent Colorectal Carcinoma, Colorectal cancer, Esophageal cancer and Adenocarcinoma. His Radiation therapy research is multidisciplinary, incorporating perspectives in Neuroendocrine tumors, Scintigraphy, Fiducial marker and Dosimetry.
His scientific interests lie mostly in Radiology, Positron emission tomography, Nuclear medicine, Internal medicine and Oncology. The various areas that Farrokh Dehdashti examines in his Radiology study include Cervical cancer, Prospective cohort study, Carcinoma and Metastasis. His research investigates the connection between Positron emission tomography and topics such as Pathology that intersect with problems in Cancer research.
His research in Nuclear medicine intersects with topics in Lung cancer and Radiation therapy. His studies deal with areas such as Gastroenterology, Endocrinology, Fdg uptake and Surgery as well as Internal medicine. His Oncology research incorporates elements of Locally advanced and Chemotherapy.
Positron emission tomography, Radiology, Internal medicine, Nuclear medicine and Oncology are his primary areas of study. Farrokh Dehdashti works on Positron emission tomography which deals in particular with Fluorodeoxyglucose. His Radiology research incorporates themes from Cervical cancer, Disease and Lymph node.
He works mostly in the field of Internal medicine, limiting it down to topics relating to Standardized uptake value and, in certain cases, Tissue microarray and Chemoradiotherapy, as a part of the same area of interest. When carried out as part of a general Nuclear medicine research project, his work on Dosimetry is frequently linked to work in Chin, therefore connecting diverse disciplines of study. His work in Oncology covers topics such as Chemotherapy which are related to areas like Hematopoietic stem cell transplantation, Radioimmunotherapy and Pre targeting.
Farrokh Dehdashti spends much of his time researching Positron emission tomography, Internal medicine, Radiology, Breast cancer and Magnetic resonance imaging. His Positron emission tomography study is concerned with Nuclear medicine in general. His Nuclear medicine research includes themes of Effective diffusion coefficient, Prospective cohort study and Diffusion MRI.
His biological study spans a wide range of topics, including Gastroenterology and Oncology. His work on Imaging modalities, Fdg pet ct and Pet mr imaging as part of his general Radiology study is frequently connected to Modalities, thereby bridging the divide between different branches of science. The study incorporates disciplines such as Immunohistochemistry and Cancer research in addition to Breast cancer.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer.
Jeffrey Bradley;Wade L. Thorstad;Sasa Mutic;Tom R. Miller.
International Journal of Radiation Oncology Biology Physics (2004)
Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET).
Felix G. Fernandez;Jeffrey A. Drebin;David C. Linehan;Farrokh Dehdashti.
Annals of Surgery (2004)
A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy.
K.S.Clifford Chao;Walter R Bosch;Sasa Mutic;Jason S Lewis.
International Journal of Radiation Oncology Biology Physics (2001)
Lymph Node Staging by Positron Emission Tomography in Patients With Carcinoma of the Cervix
Perry W. Grigsby;Barry A. Siegel;Farrokh Dehdashti.
Journal of Clinical Oncology (2001)
Metabolic flare: indicator of hormone responsiveness in advanced breast cancer.
Joanne E. Mortimer;Farrokh Dehdashti;Barry A. Siegel;Kathryn Trinkaus.
Journal of Clinical Oncology (2001)
In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM
Farrokh Dehdashti;Mark A. Mintun;Jason S. Lewis;Jeffrey Bradley.
European Journal of Nuclear Medicine and Molecular Imaging (2003)
Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: relationship to therapeutic response-a preliminary report.
Farrokh Dehdashti;Perry W Grigsby;Mark A Mintun;Jason S Lewis.
International Journal of Radiation Oncology Biology Physics (2003)
Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum
Mark H. Whiteford;Heather M. Whiteford;Laurence F. Yee;Olagunju A. Ogunbiyi.
Diseases of The Colon & Rectum (2000)
FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features.
Kevin L. Berger;Siobhan A. Nicholson;Farrokh Dehdashti;Barry A. Siegel.
American Journal of Roentgenology (2000)
Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography
F L Flanagan;F Dehdashti;B A Siegel;D D Trask.
American Journal of Roentgenology (1997)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: